Cargando…

Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study

OBJECTIVE: To identify trends in patient presentation and outcomes data that may guide the development of clinical algorithms on Merkel Cell Carcinoma (MCC). METHODS: We performed a retrospective cohort study searching in the National Cancer Institute's SEER registry for documented MCC cases fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezaldein, Harib H., Ventura, Alessandra, DeRuyter, Nicolaas P., Yin, Emily S., Giunta, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616203/
https://www.ncbi.nlm.nih.gov/pubmed/28966943
http://dx.doi.org/10.18632/oncoscience.358
_version_ 1783266728651784192
author Ezaldein, Harib H.
Ventura, Alessandra
DeRuyter, Nicolaas P.
Yin, Emily S.
Giunta, Alessandro
author_facet Ezaldein, Harib H.
Ventura, Alessandra
DeRuyter, Nicolaas P.
Yin, Emily S.
Giunta, Alessandro
author_sort Ezaldein, Harib H.
collection PubMed
description OBJECTIVE: To identify trends in patient presentation and outcomes data that may guide the development of clinical algorithms on Merkel Cell Carcinoma (MCC). METHODS: We performed a retrospective cohort study searching in the National Cancer Institute's SEER registry for documented MCC cases from 1986-2013. No exclusion criteria were applied. We hereby identified 7,831 original MCC entries. Demographics, staging, and socioeconomic characteristics were identified and treatment modality likelihoods and survival data were calculated via logistic regression and Kaplan-Meier statistical modeling. RESULTS: Concerning tumor localization, 44.5% (n= 3,485) were located on the head and neck, and 47.8% were located on the trunk and extremities (n= 3,742). Male and younger patients are more likely to receive radiation than surgery with no differences seen among patient race. Caucasians and “Other” races both showed higher overall survival than African American patients. States with higher median household income levels demonstrated survival advantage. Income quartiles yielded no differences in surgical or radiotherapy interventions. Moreover, patients who forego radiotherapy had a poorer overall survival. LIMITATIONS: Generalizability of SEER data, potential intrinsic coding inconsistencies, and limited information on patient comorbidities, sentinel lymph node and surgical margin status are major limitations. There is no information regarding medical intervention such as systemic chemotherapy or immunotherapy. Recoding efforts are inconclusive regarding variables such as tumor infiltrating lymphocytes, mutations, or immunosuppression status, which are well-documented for other cancers within the database. CONCLUSION: MCC lesions of the head and neck region, lower income quartiles, and African American race are associated with higher mortality. MCC patients have a median household income that is significantly higher than national values with no significant difference in subsequent treatment modalities (surgery or radiotherapy) based on socioeconomic markers. A lack of radiotherapy is associated with higher mortality.
format Online
Article
Text
id pubmed-5616203
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56162032017-09-29 Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study Ezaldein, Harib H. Ventura, Alessandra DeRuyter, Nicolaas P. Yin, Emily S. Giunta, Alessandro Oncoscience Research Paper OBJECTIVE: To identify trends in patient presentation and outcomes data that may guide the development of clinical algorithms on Merkel Cell Carcinoma (MCC). METHODS: We performed a retrospective cohort study searching in the National Cancer Institute's SEER registry for documented MCC cases from 1986-2013. No exclusion criteria were applied. We hereby identified 7,831 original MCC entries. Demographics, staging, and socioeconomic characteristics were identified and treatment modality likelihoods and survival data were calculated via logistic regression and Kaplan-Meier statistical modeling. RESULTS: Concerning tumor localization, 44.5% (n= 3,485) were located on the head and neck, and 47.8% were located on the trunk and extremities (n= 3,742). Male and younger patients are more likely to receive radiation than surgery with no differences seen among patient race. Caucasians and “Other” races both showed higher overall survival than African American patients. States with higher median household income levels demonstrated survival advantage. Income quartiles yielded no differences in surgical or radiotherapy interventions. Moreover, patients who forego radiotherapy had a poorer overall survival. LIMITATIONS: Generalizability of SEER data, potential intrinsic coding inconsistencies, and limited information on patient comorbidities, sentinel lymph node and surgical margin status are major limitations. There is no information regarding medical intervention such as systemic chemotherapy or immunotherapy. Recoding efforts are inconclusive regarding variables such as tumor infiltrating lymphocytes, mutations, or immunosuppression status, which are well-documented for other cancers within the database. CONCLUSION: MCC lesions of the head and neck region, lower income quartiles, and African American race are associated with higher mortality. MCC patients have a median household income that is significantly higher than national values with no significant difference in subsequent treatment modalities (surgery or radiotherapy) based on socioeconomic markers. A lack of radiotherapy is associated with higher mortality. Impact Journals LLC 2017-09-14 /pmc/articles/PMC5616203/ /pubmed/28966943 http://dx.doi.org/10.18632/oncoscience.358 Text en Copyright: © 2017 Ezaldein et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Ezaldein, Harib H.
Ventura, Alessandra
DeRuyter, Nicolaas P.
Yin, Emily S.
Giunta, Alessandro
Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study
title Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study
title_full Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study
title_fullStr Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study
title_full_unstemmed Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study
title_short Understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study
title_sort understanding the influence of patient demographics on disease severity, treatment strategy, and survival outcomes in merkel cell carcinoma: a surveillance, epidemiology, and end-results study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616203/
https://www.ncbi.nlm.nih.gov/pubmed/28966943
http://dx.doi.org/10.18632/oncoscience.358
work_keys_str_mv AT ezaldeinharibh understandingtheinfluenceofpatientdemographicsondiseaseseveritytreatmentstrategyandsurvivaloutcomesinmerkelcellcarcinomaasurveillanceepidemiologyandendresultsstudy
AT venturaalessandra understandingtheinfluenceofpatientdemographicsondiseaseseveritytreatmentstrategyandsurvivaloutcomesinmerkelcellcarcinomaasurveillanceepidemiologyandendresultsstudy
AT deruyternicolaasp understandingtheinfluenceofpatientdemographicsondiseaseseveritytreatmentstrategyandsurvivaloutcomesinmerkelcellcarcinomaasurveillanceepidemiologyandendresultsstudy
AT yinemilys understandingtheinfluenceofpatientdemographicsondiseaseseveritytreatmentstrategyandsurvivaloutcomesinmerkelcellcarcinomaasurveillanceepidemiologyandendresultsstudy
AT giuntaalessandro understandingtheinfluenceofpatientdemographicsondiseaseseveritytreatmentstrategyandsurvivaloutcomesinmerkelcellcarcinomaasurveillanceepidemiologyandendresultsstudy